![pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons](../news/img/healthcare/pills_rapid_release_pills_By_Katy_Warner_from_Orlando_FL_USA_[CC-BY-SA-3.0_(http_creativecommons.org_licenses_by-sa_3.0)]_via_Wikimedia_Commons.jpg)
For the first quarter of 2022 Mei Pharma Inc decreased a loss per share of $-0.12 per share compare to $-0.18 a year before and Income per Share improved from $-0.13 per share from the previous quarter.
Revenues were up by 12.544 % to $
8.73 millions from $7.76 millions in the comparable quarter a year before and sequentially Revenues fell by -23.515 % from $11.41 millions.
As the company assists corporate clients to prosper, and thrive, MEIP is pursuing the chances and spreading respective market share.
In the first quarter of 2022 Mei Pharma Inc reported net shortfall of $-16.624 million, instead of deficit of $-17.510 millions in the comparable quarter a year ago.
Mei Pharma Inc is expected to report next financial recent numbers on February 09, 2023.